Trifluoroacetic acid → HCID 178493958, compound
Reaction equation
[CH:1]([C:4]1[N:5]=[C:6]([CH2:9][CH2:10][C:11]2[CH:37]=[CH:36][N:14]3[C:15](=[O:35])[C:16]([C:21]4[N:22]=[N:23][N:24](CC5C=CC(OC)=CC=5)[N:25]=4)=[C:17]([O:19][CH3:20])[N:18]=[C:13]3[CH:12]=2)[S:7][CH:8]=1)([CH3:3])[CH3:2].FC(F)(F)C(O)=O.C1(OC)C=CC=CC=1>>[CH:1]([C:4]1[N:5]=[C:6]([CH2:9][CH2:10][C:11]2[CH:37]=[CH:36][N:14]3[C:15](=[O:35])[C:16]([C:21]4[NH:25][N:24]=[N:23][N:22]=4)=[C:17]([O:19][CH3:20])[N:18]=[C:13]3[CH:12]=2)[S:7][CH:8]=1)([CH3:3])[CH3:2]Participants
4
Procedure
The 8-[2-(4-isopropyl-1,3-thiazol-2-yl)ethyl]-2-methoxy-3-[2-(4-methoxy-benzyl)-2H-1,2,3,4-tetrazol-5-yl]-4H-pyrido[1,2-a]pyrimidin-4-one (5 mg) obtained in (A) was added with trifluoroacetic acid (0.3 ml) and anisole (0.1 ml) and stirred for 2 days. The solvent was evaporated under reduced pressure, and the residue was added with hexane and ethyl acetate. Insoluble solids were collected by filtration and dried to obtain the title compound (1.2 mg).
Workup
- customThe solvent was evaporated under reduced pressure
- additionthe residue was added with hexane and ethyl acetate
- filtrationInsoluble solids were collected by filtration
- customdried
Sources & evidence
- ORD record
- ord-e2697f7f96ae48f38a53b5aed1eaa938
- Source dataset
- uspto-grants-2006_06
- Patent number
- US07056917B2
Reaction notes
Loading…